Meta-analysis on the Role of High-sensitivity C-reactive Protein Monitoring in Relation to the Presence of Glucose Intolerance in Patients Treated with HMG-CoA Reductase Inhibitors-Reference-Cited by-同舟云学术

Meta-analysis on the Role of High-sensitivity C-reactive Protein Monitoring in Relation to the Presence of Glucose Intolerance in Patients Treated with HMG-CoA Reductase Inhibitors

Published:2012 Issue:8 Volume:38 Page:479-490
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Kiribayashi Mio,Echizen Hirotoshi

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference65 articles.

1. 1) Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium, Hingorani AD, Casas JP, The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis, Lancet, 2012, 379, 1214-1224.

2. 2) IL6R Genetics Consortium Emerging Risk Factors Collaboration, Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies, Lancet, 2012, 379, 1205-1213.

3. 3) Koenig W, Löwel H, Baumert J, Meisinger C, C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany, Circulation, 2004, 109, 1349-1353.

4. 4) Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 2008, 359, 2195-2207.

5. 5) Heart Protection Study Collaborative Group, Emberson J, Bennett D, Link E, Parish S, Danesh J, Armitage J, Collins R, C-reactive protein concentration and the vascular benefits of statin therpy: an analysis of 20536 patients in the Heart Protection Study, Lancet, 2011, 377, 469-476.